Growth Metrics

Curis (CRIS) EBIT Margin (2016 - 2025)

Curis (CRIS) has disclosed EBIT Margin for 16 consecutive years, with 218.01% as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, EBIT Margin rose 14252.0% year-over-year to 218.01%, compared with a TTM value of 294.64% through Sep 2025, up 17077.0%, and an annual FY2024 reading of 408.34%, up 7387.0% over the prior year.
  • EBIT Margin was 218.01% for Q3 2025 at Curis, up from 300.15% in the prior quarter.
  • Across five years, EBIT Margin topped out at 218.01% in Q3 2025 and bottomed at 735.68% in Q1 2022.
  • Average EBIT Margin over 5 years is 440.84%, with a median of 436.57% recorded in 2023.
  • The sharpest move saw EBIT Margin tumbled -33367bps in 2022, then soared 22950bps in 2023.
  • Year by year, EBIT Margin stood at 400.86% in 2021, then rose by 12bps to 354.0% in 2022, then decreased by -28bps to 452.49% in 2023, then soared by 41bps to 268.88% in 2024, then grew by 19bps to 218.01% in 2025.
  • Business Quant data shows EBIT Margin for CRIS at 218.01% in Q3 2025, 300.15% in Q2 2025, and 426.76% in Q1 2025.